SYNTHON

Welcome to the Brand page for “SYNTHON”, which is offered here for Treatment of materials for the manufacture of pharmaceutical and biopharmaceutical preparations; manufacture, for others, of pharmaceutical and biopharmaceutical preparations and raw materials for the pharmaceutical industry;pharmaceutical preparations, substances and compositions for the treatment of cancer, multiple sclerosis and other disorders in the central nervous system, neoplasms and autoimmune diseases as well as other diseases; biological and biochemical drug and cultures for medical use, biological tissue cultures for medical purposes; culture fluids for cultivating human, and animal cells and plants, plant cells or plant tissues; culture media for cultivating human, and animal cells and plants, plant cells or plant tissues; media for use in culturing eukaryotic cells; pharmaceutical biological and biochemical drugs for the treatment of neoplasms and autoimmune diseases;office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of agreements regarding the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration dossiers; business advice and information; business consultation; procurement of contracts for others for the purchase and sale of goods; business services, compiling of pharmaceutical registration dossiers for others;legal services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; legal services, management of intellectual property, know-how and copyright; licensing of intellectual property and know-how, including dossiers for obtaining pharmaceutical registrations; providing legal services and information in the field of intellectual property; legal advice in the field of intellectual property;surgical devices and instruments; injection apparatus for medical purposes, injectors and syringes for medical purposes and for injections;scientific laboratory services; scientific research and development; scientific and technological services, scientific analysis and testing services in the field of pharmaceuticals and pharmaceutical ingredients; scientific consultation services in the field of pharmaceuticals and pharmaceutical ingredients; scientific investigations for medical purposes; pharmaceutical research and development; pharmaceutical drug development services; laboratory research services relating to pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research and development; biomedical research and consultancy; medical research; medical laboratories; chemistry and biology laboratories; scientific laboratory services; development of pharmaceutical products and ingredients; providing medical and scientific research information in the field of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; quality management services, quality evaluation and analysis, quality assurance and quality control, in the field of pharmaceuticals; laboratory research and laboratory analysis services relating to pharmaceuticals and pharmaceutical ingredients; research and scientific design of pharmaceutical products and ingredients for the pharmaceutical industry; research and development in the field of oncology, central nervous system, neoplasms and autoimmune diseases and life-threatening diseases; drug discovery; product quality testing; conducting clinical trials for pharmaceutical preparations; conducting quality control of pharmaceutical preparations; providing information and data relating to pharmaceutical research and developments, biopharmaceutical research and developments and medical research and developments;.

Its status is currently believed to be active. Its class is unavailable. “SYNTHON” is believed to be currently owned by “SYNTHON HOLDING B.V.”